Children with Muscular Disorders
You're doing a clinical rotation with Dr. Barr, a world-renowned specialist in children's muscle disorders. On your first day, you meet three patients with the same probable diagnosis—nemaline myopathy. Jodi, age 2, has a waddling walk and difficulty standing; Linda. 6 months, has pneumonia associated with problems swallowing; and Tom, 12, has progressive weakness with foot drop and difficulty walking.
“This kind of variation is not surprising.” says Dr. Barr. “A mutation in one of 11 different genes related to thin filaments can cause nemaline myopathy, so you’d expect to see it present in different ways.”
Dr. Barr has scheduled all three children for a muscle biopsy (surgical removal of a small piece of muscle tissue for examination). He explains to you. “We’re going to use these biopsies for two things. First, we're going to look for the characteristic histology of nemaline myopathy. Second, we're going to test for malignant hyperthermia. It's not associated with nemaline myopathy but is associated with a different myopathy that has a similar presentation.”
1. What does actin do? What consequences would you expect from an abnormality in actin?
Want to see the full answer?
Check out a sample textbook solutionChapter 9 Solutions
Human Anatomy & Physiology Plus Mastering A&P with Pearson eText -- Access Card Package (11th Edition) (What's New in Anatomy & Physiology)
- 1) Paula is a scientist who is developing a drug called Fremtol that will be used to treat muscle spasms. This drug acts on specific skeletal muscles to (1) block the release of Ca2+ ions from the sarcoplasmic reticulum, (2) inhibit the pivoting ability of the myosin heads of the thick filaments, and (3) block the production of ATP by the mitochondria in skeletal muscles. By using this drug, contraction of certain skeletal muscle fibers is reduced, which keeps those muscles from producing spasms. In the above scenario, Fremtol’s effect of blocking the pivoting ability of the myosin heads of the thick filaments would have which of the following consequences? a. decreased release of acetylcholine at the neuromuscular junction b. inhibition of the power stroke c. reduced production of myoglobin d. All of the above e. None of the above 2) Paula is a scientist who is developing a drug called Fremtol that will be used to treat muscle spasms. This drug acts on specific skeletal muscles to…arrow_forwardMuscular Dystrophy (MD) is the name of a group of muscle disorders that are characterized by progressive weakness and wasting of the voluntary muscles that control body movement. As muscle tissue weakens and wastes away, it is replaced by fatty and connective tissue. Duchenne muscular dystrophy is the most severe form of dystrophinopathy . It occurs mostly in young boys and is the most common form of MD that affects children. Which of the following would NOT likely be a sign or symptom of Duchenne muscular dystrophy ? A)lack of peristalsis in the digestive tract b)frequent falls c) weakness in lower leg muscles, resulting in difficulty running and jumping D) difficulty getting up from a lying or sitting positionarrow_forwardTroponin C has been mutated such that it cannot bind to calcium. Describe the effect of this mutation on sarcomere shortening in skeletal muscle. A complete answer will describe the normal function of troponin C, the normal process of sarcomere shortening, and will describe the overall effect of the mutation on sarcomere shortening based on troponin C's function and its role in the overall process of sarcomere shortening.arrow_forward
- 2) Paula is a scientist who is developing a drug called Fremtol that will be used to treat muscle spasms. This drug acts on specific skeletal muscles to (1) block the release of Ca2+ ions from the sarcoplasmic reticulum, (2) inhibit the pivoting ability of the myosin heads of the thick filaments, and (3) block the production of ATP by the mitochondria in skeletal muscles. By using this drug, contraction of certain skeletal muscle fibers is reduced, which keeps those muscles from producing spasms. In the above scenario, Fremtol’s effect of blocking the release of Ca2+ ions from the sarcoplasmic reticulum would most directly prevent which the following? a. activation of tropomyosin b. activation of troponin c. activation of actin d. All of the above e. None of the abovearrow_forwardDiscuss the notion that intense exercise might result in permanent damage to (b) the musculoskeletal system in children.arrow_forwardplease answer 6 7 8arrow_forward
- Indicate whether the sentences 4, 5 and 11 is True or Falsearrow_forwardthis is an anotomy/physilogy questionarrow_forwardMen are generally stronger than women because they typically have larger bodies, and a more significant proportion of their total body mass is made up of muscle. However, when strength is expressed per unit of the cross-sectional area of muscle tissue, men are only 1-2% stronger than women in the upper body and equal to women in the lower body. Explain two factors that explain these disparities.arrow_forward
- What are the side effects of Muscular dystrophies?arrow_forward3) Paula is a scientist who is developing a drug called Fremtol that will be used to treat muscle spasms. This drug acts on specific skeletal muscles to (1) block the release of Ca2+ ions from the sarcoplasmic reticulum, (2) inhibit the pivoting ability of the myosin heads of the thick filaments, and (3) block the production of ATP by the mitochondria in skeletal muscles. By using this drug, contraction of certain skeletal muscle fibers is reduced, which keeps those muscles from producing spasms. In the above scenario, Fremtol’s effect of blocking muscle mitochondrial ATP production would result in the inability of the muscle to make ATP from ___________. a. creatine phosphate b. anaerobic glycolysis c. aerobic respiration d. All of the above e. None of the abovearrow_forwardWhat event occurs immediately before the movement of tropomyosin? Initiation of the power stroke Cross bridge formation Active sites on actin are revealed Release of calcium from terminal cisternae Troponin changes shapearrow_forward
- Comprehensive Medical Assisting: Administrative a...NursingISBN:9781305964792Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy CorreaPublisher:Cengage LearningMedical Terminology for Health Professions, Spira...Health & NutritionISBN:9781305634350Author:Ann Ehrlich, Carol L. Schroeder, Laura Ehrlich, Katrina A. SchroederPublisher:Cengage Learning